SPX4,071.70-4.87 -0.12%
DIA344.74+0.33 0.10%
IXIC11,461.50-20.95 -0.18%

--HC Wainwright Adjusts Intercept Pharmaceuticals Price Target to $14 From $16, Maintains Neutral Rating

--HC Wainwright Adjusts Intercept Pharmaceuticals Price Target to $14 From $16, Maintains Neutral Rating

MT Newswires · 11/16/2022 06:58

Please log in to view news